EPOCH and Rituximab to Treat Non-Hodgkin's Lymphoma in Patients With HIV Infection

NCT00006436 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

68

Enrollment

NIH

Sponsor class

Conditions

Lymphoma, AIDS-related
Lymphoma, Large B-Cell, Diffuse

Interventions

BIOLOGICAL: Rituximab
BIOLOGICAL: Filgrastim
DRUG: EPOCH

Sponsor

National Cancer Institute (NCI)